43rd Annual Chemotherapy Foundation Symposium (CFS): Innovative Cancer Therapy for Tomorrow®

43rd Annual Chemotherapy Foundation Symposium (CFS): Innovative Cancer Therapy for Tomorrow® is organized by Physicians' Education Resource, LLC (PER) and will be held from Nov 12 - 14, 2025 at New York Hilton Midtown, New York City, New York, United States of America.

Description:
Now in its 43rd year, the Chemotherapy Foundation Symposium (CFS®) brings together thousands of health care professionals for an exciting 3-day conference that promotes the delivery of evidence-based, state-of-the-art cancer care. Internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering a unique opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize clinical care for your patients with cancer.

Exciting new developments and rapid changes continue to occur in the management of solid and hematologic malignancies. In the past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to do so. Optimized testing and treatments for early and advanced disease, including chemotherapeutics, targeted therapies, immunotherapies—alone and in combination—and multimodal strategies continue to improve clinical outcomes. CFS® offers you the critical knowledge you need to safely and effectively integrate these strategies into your practice.

Learning Objectives:

• Compare the risks and benefits of treatment regimens based on recent clinical trials across solid and liquid tumors
• Apply strategies to identify and mitigate treatment-related adverse effects associated with solid and liquid tumor treatment approaches
• Incorporate individual patient and disease characteristics in treatment decisions to optimally manage solid and liquid tumors
• Determine optimal therapy based on biomarker testing across multiple solid and liquid tumors